NATIONAL HARBOR, Md. -- A combination of high-dose immunosuppressive therapy and autologous hematopoietic cell transplantation resulted in [...]
For the first time, scientists say they’ve discovered a genetic mutation linked to a rare type of multiple sclerosis, and they are hoping [...]
EMD Serono, the U.S. and Canadian subsidiary and biopharmaceutical business of Merck KGaA, focuses exclusively on specialty care. With [...]
A symposium focused on lifestyle factors and unconventional medicine as part of the clinical care provided to patients with multiple [...]
As the Consortium of Multiple Sclerosis Centers (CMSC) celebrates its 30th anniversary, Multiple Sclerosis News Today talked with its [...]
Dr. Fred Lublin, a renowned multiple sclerosis (MS) expert at Mount Sinai Medical Center, helped launch the Consortium of Multiple [...]
The Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting began today, June 1. Multiple Sclerosis News Today is providing [...]
Multiple sclerosis patients taking the drug mitoxantrone had a higher incidence of colorectal cancer and acute myeloid leukemia (AML) than [...]
Multiple Sclerosis News Today will provide extended on-site coverage of the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual [...]
Multiple Sclerosis (MS) is a neurological disease, characterised by demyelination and the onset of chronic, neurodegenerative damage of the [...]
